Economic Studies in Motor Neurone Disease: A Systematic Methodological Review Alan MooreCarolyn A. YoungDyfrig A. Hughes Systematic Review 14 December 2016 Pages: 397 - 413
Cabazitaxel for Hormone-Relapsed Metastatic Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal Benjamin KearnsAbdullah PandorM. Satish Kumar Review Article 22 October 2016 Pages: 415 - 424
Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin Lymphoma Kelly FustXiaoyan LiGary H. Lyman Original Research Article Open access 07 December 2016 Pages: 425 - 438
Is Dimension Order Important when Valuing Health States Using Discrete Choice Experiments Including Duration? Brendan MulhernRichard NormanRosalie Viney Original Research Article 21 November 2016 Pages: 439 - 451
Mapping CHU9D Utility Scores from the PedsQLTM 4.0 SF-15 Christine Mpundu-KaambwaGang ChenJulie Ratcliffe Original Research Article 07 December 2016 Pages: 453 - 467
Measuring Care-Related Quality of Life of Caregivers for Use in Economic Evaluations: CarerQol Tariffs for Australia, Germany, Sweden, UK, and US Renske J. HoefmanJob van ExelWerner B. F. Brouwer Original Research Article Open access 31 December 2016 Pages: 469 - 478
A Cost-Effectiveness Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in the UK C. RinciogM. WatkinsA. Diamantopoulos Original Research Article Open access 31 December 2016 Pages: 479 - 491
